Literature DB >> 22561122

FICZ, a tryptophan photoproduct, suppresses pulmonary eosinophilia and Th2-type cytokine production in a mouse model of ovalbumin-induced allergic asthma.

Kyu-Tae Jeong1, Sung-Jun Hwang, Gap-Soo Oh, Joo-Hung Park.   

Abstract

Most studies about functions of aryl hydrocarbon receptor (AhR) in the pathogenesis of asthma have been carried out with non-physiological industrial by-products such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and benzo(a)pyrene. In the present study, effects of 6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan photoproduct postulated as a candidate physiological ligand of AhR, on the pathogenesis of asthma were examined and then underlying mechanisms of its immumodulatory effects were investigated. FICZ significantly reduced pulmonary eosinophilia and Th2 cytokine expression in the lungs. Flow cytometric analysis of mediastinal lymph nodes showed that IL-4 producing cells decreased in FICZ-treated mice compared with PBS control. Next, effects of FICZ on in vitro Th2 differentiation and expression of the Th2 transcription factor GATA-3 were examined. CD4+ T cells were isolated from the spleen and incubated under the Th2 differentiation conditions. FICZ inhibited both Th2 differentiation and the expression of GATA-3. Finally, activation of STAT6, which is necessary for Th2 differentiation, was inhibited by FICZ.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561122     DOI: 10.1016/j.intimp.2012.04.014

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  21 in total

Review 1.  The impact of diet on asthma and allergic diseases.

Authors:  Valerie Julia; Laurence Macia; David Dombrowicz
Journal:  Nat Rev Immunol       Date:  2015-05       Impact factor: 53.106

2.  Bronchial epithelial innate and adaptive immunity signals are induced by polycyclic aromatic hydrocarbons.

Authors:  Kirsty Meldrum; Timothy W Gant; Sameirah Macchiarulo; Martin O Leonard
Journal:  Toxicol Res (Camb)       Date:  2016-02-09       Impact factor: 3.524

3.  Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?

Authors:  Allison K Ehrlich; Nancy I Kerkvliet
Journal:  Curr Opin Toxicol       Date:  2017-02-01

Review 4.  Aryl hydrocarbon receptor control of adaptive immunity.

Authors:  Francisco J Quintana; David H Sherr
Journal:  Pharmacol Rev       Date:  2013-08-01       Impact factor: 25.468

5.  Platinum-catalyzed tandem indole annulation/arylation for the synthesis of diindolylmethanes and indolo[3,2-b]carbazoles.

Authors:  Dongxu Shu; Gabrielle N Winston-McPherson; Wangze Song; Weiping Tang
Journal:  Org Lett       Date:  2013-08-05       Impact factor: 6.005

Review 6.  Hypoxia and Mucosal Inflammation.

Authors:  Sean P Colgan; Eric L Campbell; Douglas J Kominsky
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

7.  Synthesis and biological evaluation of 2,3'-diindolylmethanes as agonists of aryl hydrocarbon receptor.

Authors:  Gabrielle N Winston-McPherson; Dongxu Shu; Weiping Tang
Journal:  Bioorg Med Chem Lett       Date:  2014-06-18       Impact factor: 2.823

8.  Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus.

Authors:  Jennifer L H Wheeler; Kyle C Martin; Emily Resseguie; B Paige Lawrence
Journal:  Toxicol Sci       Date:  2013-11-05       Impact factor: 4.849

9.  Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.

Authors:  Ellen H van den Bogaard; Judith G M Bergboer; Mieke Vonk-Bergers; Ivonne M J J van Vlijmen-Willems; Stanleyson V Hato; Pieter G M van der Valk; Jens Michael Schröder; Irma Joosten; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

Review 10.  Role of the aryl hydrocarbon receptor (AhR) in lung inflammation.

Authors:  Celine A Beamer; David M Shepherd
Journal:  Semin Immunopathol       Date:  2013-08-21       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.